KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Total Debt (2018 - 2026)

Takeda Pharmaceutical has reported Total Debt over the past 9 years, most recently at $27.9 billion for Q1 2026.

  • For Q1 2026, Total Debt fell 46.41% year-over-year to $27.9 billion; the TTM value through Mar 2026 reached $27.9 billion, down 46.41%, while the annual FY2026 figure was $29.0 billion, 44.26% down from the prior year.
  • Total Debt was $27.9 billion for Q1 2026 at Takeda Pharmaceutical, down from $52.0 billion in the prior quarter.
  • Across five years, Total Debt topped out at $52.0 billion in Q1 2025 and bottomed at $5.6 billion in Q1 2024.
  • The 5-year median for Total Debt is $27.9 billion (2026), against an average of $24.9 billion.
  • Year-over-year, Total Debt tumbled 83.07% in 2024 and then skyrocketed 826.98% in 2025.
  • Over 5 years, Total Debt stood at $5.7 billion in 2022, then soared by 478.96% to $33.1 billion in 2023, then tumbled by 83.07% to $5.6 billion in 2024, then skyrocketed by 826.98% to $52.0 billion in 2025, then tumbled by 46.41% to $27.9 billion in 2026.
  • The last three reported values for Total Debt were $27.9 billion (Q1 2026), $52.0 billion (Q1 2025), and $5.6 billion (Q1 2024) per Business Quant data.